Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 6. Use of bisphosphonates in the treatment of osteoporosis.

Abstract

OBJECTIVE: To describe the mechanisms of action of bisphosphonates in the treatment of osteoporosis and compare bisphosphonate therapy with other treatments. OPTIONS: The bisphosphonates, etidronate, alendronate, clodronate, pamidronate, tiludronate, ibandronate and risedronate; combined bisphosphonates and estrogen; combined bisphosphonates and calcium supplements.

Authors

Hodsman A; Adachi J; Olszynski W

Journal

Canadian Medical Association Journal, Vol. 155, No. 7, pp. 945–948

Publication Date

October 1, 1996

ISSN

0820-3946

Associated Experts

Jonathan Derrick Adachi

Professor Emeritus, Faculty of Health Sciences

Visit profile

Labels

Fields of Research (FoR)

3213 Paediatrics 3215 Reproductive Medicine 32 Biomedical and clinical sciences 3202 Clinical Sciences 42 Health sciences

Medical Subject Headings (MeSH)

Aged Canada Diphosphonates Female Humans Male Middle Aged Osteoporosis Societies, Medical Time Factors